Microbiome MDx specialist Genetic Analysis and Bio-Rad Sign Agreement
Bio-Rad Laboratories, Inc. Class A (BIO)
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Business Wire
Bio-Rad to Commercialize Genetic Analysis’s GA-map Technology for the Detection of Gut Dysbiosis OSLO, Norway & HERCULES, Calif.--(BUSINESS WIRE)-- Genetic Analysis (GA) and Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced that they have signed an agreement in which Genetic Analysis will receive an equity investment from Bio-Rad in exchange for commercialization rights, in certain territories, for Genetic Analysis’s GA-map™ technology to detect gut dysbiosis. Terms of the agreement were not disclosed. The patented GA-map™ technology is used as an aide in the diagnosis and management of irritable bowel syndrome and inflammatory bowel disease. Dysbiosis is a microbial imbalance or maladaptation on or inside the body and is most commonly reported as a condition in the digestive tract. It has been associated with illnesse
Show less
Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO alerts
High impacting Bio-Rad Laboratories, Inc. Class A news events
Weekly update
A roundup of the hottest topics
BIO
News
- Molecular Weight Marker Market Forecast Report 2019-2029, Featuring Bio-Rad Laboratories, Merck, New England Biolabs, Promega, QIAGEN, VWR, Takara Bio, HiMedia Laboratories and GeneDireX [Yahoo! Finance]Yahoo! Finance
- Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare ConferenceBusiness Wire
- Liquid Handling Systems Market Size Worth $8.07 billion by 2031 at a CAGR of 7.8%: Straits Research [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Announces Life Science Group Management ChangesBusiness Wire
- Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
BIO
Earnings
- 2/15/24 - Beat
BIO
Sec Filings
- 5/1/24 - Form 4
- 4/30/24 - Form 4
- 4/29/24 - Form 4
- BIO's page on the SEC website